Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03064854
Title PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
UCLA Santa Monica Hematology / Oncology SC-2 Santa Monica California 90404 United States Details
Stanford Cancer Center SC Stanford California 94305 United States Details
Henry Ford Health System SC Detroit Michigan 48202 United States Details
Washington University School of Medicine SC Saint Louis Missouri 63110 United States Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Roeselare 8800 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Praha 4 140 59 Czechia Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Marseille Cedex 05 13885 France Details
Novartis Investigative Site Gottingen 37075 Germany Details
Novartis Investigative Site Koeln 51109 Germany Details
Novartis Investigative Site Pokfulam Hong Kong Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field